RFA
IBB icon

Resurgent Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Resurgent Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-178
Closed -$24.2K – 319
2023
Q4 		$24.2K Sell
178
-600
-77% -$73.2K 0.01% 458
2023
Q3 		$95.1K Hold
778
– – 0.06% 229
2023
Q2 		$98.8K Hold
778
– – 0.07% 232
2023
Q1 		$100K Hold
778
– – 0.07% 231
2022
Q4 		$102K Buy
+778
New +$101K 0.05% 306

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Resurgent Financial Advisors's IBB Position: Q1 2024 in Review

Resurgent Financial Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2024, closing a stake of 178 shares — an estimated $24.2K sold.

Resurgent Financial Advisors first reported a position in IBB in Q4 2022 and held it in 5 quarters. The position peaked at $102K in Q4 2022. 899 funds tracked by Wall St. Rank hold IBB as of Q1 2024.

  • Resurgent Financial Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2024 after selling out during the quarter.
  • Resurgent Financial Advisors sold 178 iShares Biotechnology ETF shares in Q1 2024, an estimated $24.2K.
  • Resurgent Financial Advisors first reported a position in iShares Biotechnology ETF in Q4 2022 and held it in 5 quarters.
  • Resurgent Financial Advisors's iShares Biotechnology ETF position peaked at $102K in Q4 2022.
  • 899 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.

Based on Resurgent Financial Advisors's 13F filing for Q1 2024, filed 10 May 2024.